about
Therapeutic role of vasopressin receptor antagonism in patients with liver cirrhosis.Inducible nitric oxide synthase activity contributes to the regulation of peripheral vascular tone in patients with cirrhosis and ascitesEndothelin-1 contributes to maintenance of systemic but not portal haemodynamics in patients with early cirrhosis: a randomised controlled trial.Review article: recent advances in the management of bleeding gastric varices.Review article: liver transplantation for the pulmonary disorders of portal hypertension.Review article: advances in the management of patients with cirrhosis and portal hypertension-related renal dysfunction.Reticulocyte count and hemoglobin concentration predict survival in candidates for liver transplantation.Hepatic ischemia reperfusion injury is associated with acute kidney injury following donation after brain death liver transplantation.Editorial: monitoring blood pressure is key to the safe use of beta-blockers in patients with chronic liver failure.Inducible nitric oxide synthase activity does not contribute to the maintenance of peripheral vascular tone in patients with heart failure.Improved clinical outcome with transjugular intrahepatic portosystemic stent-shunt utilizing polytetrafluoroethylene-covered stents.Transient segmental liver ischaemia after polytetrafluoroethylene transjugular intrahepatic portosystemic stent-shunt procedure.How to tackle rising rates of liver disease in the UKThe impact of ileal pouch-anal anastomosis on graft survival following liver transplantation for primary sclerosing cholangitisA liver mass post-Fontan operationThe evolving use of higher risk grafts is associated with an increased incidence of acute kidney injury after liver transplantationHyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiencySmoking-related morbidity and mortality following liver transplantationBradykinin does not contribute to peripheral vascular tone in patients with cirrhosis and ascites
P50
Q34183840-DA1BC586-D019-4E8E-B8CF-92B78012AF63Q35760421-11C70816-5E75-468D-AF84-9093B8CA2519Q35768938-5EB3B026-04FE-4D52-B100-773DF35BF8F0Q36520760-7C7011DA-2C34-4427-920B-45DA8B8D0298Q38059261-BD661321-0EFB-4940-8D9B-A0BAFA10978DQ38188048-668FE950-ED6B-4E3F-9CE4-DA296447B6F5Q42228173-FFE2C81F-C585-421F-972A-979060F4D89FQ43865439-D026B06D-9035-4466-A642-B2CED8D328AEQ48371346-0D109C75-574A-4823-A12F-98FD35749D92Q50773444-D12CC3F0-CE97-4627-B7F1-90C18B6D8483Q51275658-A585A769-BC1C-4EE2-85E3-AF565A216109Q51559202-C98C981B-76D2-45D5-A766-74433D7FDBEBQ57710819-F01D5F9B-C9FF-4794-AB75-AD12676CAE1DQ58398894-D2B435A5-E42C-456D-AF00-279FE11D553AQ59384424-4632BBBA-4C2F-4698-A774-991425D839D5Q61796565-EEE3BDA7-65BC-47E7-B3C3-06010924D9D2Q81299199-69455A2D-0CEB-4DA0-A884-D4685AC974A5Q81722312-2E3594B3-5ADF-402B-B908-86C60E93ACDEQ83299080-19715FA9-C228-4343-8D64-E86E5E8DD807
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
James W Ferguson
@ast
James W Ferguson
@en
James W Ferguson
@es
James W Ferguson
@nl
type
label
James W Ferguson
@ast
James W Ferguson
@en
James W Ferguson
@es
James W Ferguson
@nl
altLabel
james ferguson
@en
prefLabel
James W Ferguson
@ast
James W Ferguson
@en
James W Ferguson
@es
James W Ferguson
@nl
P214
P244
P5361
P106
P214
P244
n2013181344
P31
P496
0000-0002-2529-0409
P5361
FergusonJames1975-
P734
P735
P7859
lccn-n2013181344